BioNTech’s New Chapter: A Shift from Pandemic Success to Pioneering Cancer Therapies
BioNTech transitions from its pandemic focus, targeting cancer treatment with mRNA technology. Despite declining profits in 2024, BioNTech's financial performance exceeded Wall Street expectations, reflecting resilience and adaptability. Projected revenue…